Showing 1991-2000 of 9943 results for "".
Take 5: Innovations in Aesthetic Treatments
https://practicaldermatology.com/columns/take-5/take-5-innovations-in-aesthetic-treatments/21746/Five new or emerging products may expand skin rejuvenation options.DermTube Highlights
https://practicaldermatology.com/topics/general-topics/dermtube-highlights/21767/Here's a guide to some of the latest videos posted at the educational video file sharing site developed specifically for dermatologists.An Update on Hair Transplantation
https://practicaldermatology.com/topics/general-topics/an-update-on-hair-transplantation/22021/For the dermatologists interested in expanding the service menu or offering the best advice to patients, here's an update on the latest advancements in hair transplantation.How Viable is Pay-for-Performance in Dermatology?
https://practicaldermatology.com/topics/general-topics/PD0509_03-php/22825/Though Pay-for-Performance has affected primary care medicine for years, it has only recently expanded into specialized medicine. Experts discuss its eventual impact on dermatology.Pearls for Choosing and Initiating Psoriasis Therapy
https://practicaldermatology.com/topics/psoriasis/PD0309_18-php/22872/Members of the psoriasis panel at the 2009 South Beach Symposium last month offered insights on patient care.Who's Responsible for Your Receivables?
https://practicaldermatology.com/topics/general-topics/PD0109_02-php/22889/When it comes to timely collection of payments, different staff members have important responsibilities.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20945/Viagra and Aggressive Melanoma: Is There a Link?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/viagra-and-aggressive-melanoma-is-there-a-link/20998/New findings offer insight into the possible effects of the popular prescription on melanoma growth.DermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-3-year-clinical-data-lebrikizumab/28648/Study author Melinda Gooderham, MSc, MD, FRCPC, discusses the new three-year clinical data presented at the European Academy of Dermatology & Venereology (EADV) Congress on the efficacy and safety of lebrikizumab, which the FDA recently approved on September 13 for adults and adolescents with moNIH Analysis Examines Association Between AD and Comorbidities
https://practicaldermatology.com/programs/practical-dermatology-atopic-dermatitis/nih-analysis-examines-association-between-ad-and-comorbidities/27113/In this week's DermwireTV, new NIH data looks at the association between AD and several health conditions; a study evaluates the effect of lebrikizumab monotherapy in patients with moderate-to-severe AD over 16 weeks; and Andrew Mastro provides tips on how to optimize the first 5 minutes with a pati